NCT05849662 2024-11-12A Phase I/II Study of Trametinib and Azacitidine for Patients With Newly Diagnosed Juvenile Myelomonocytic LeukemiaTherapeutic Advances in Childhood Leukemia ConsortiumPhase 1/2 Recruiting58 enrolled